Challenge and opportunity for vector control strategies on key mosquito-borne diseases during the COVID-19 pandemic
- PMID: 37554733
- PMCID: PMC10405932
- DOI: 10.3389/fpubh.2023.1207293
Challenge and opportunity for vector control strategies on key mosquito-borne diseases during the COVID-19 pandemic
Abstract
Mosquito-borne diseases are major global health problems that threaten nearly half of the world's population. Conflicting resources and infrastructure required by the coronavirus disease 2019 (COVID-19) global pandemic have resulted in the vector control process being more demanding than ever. Although novel vector control paradigms may have been more applicable and efficacious in these challenging settings, there were virtually no reports of novel strategies being developed or implemented during COVID-19 pandemic. Evidence shows that the COVID-19 pandemic has dramatically impacted the implementation of conventional mosquito vector measures. Varying degrees of disruptions in malaria control and insecticide-treated nets (ITNs) and indoor residual spray (IRS) distributions worldwide from 2020 to 2021 were reported. Control measures such as mosquito net distribution and community education were significantly reduced in sub-Saharan countries. The COVID-19 pandemic has provided an opportunity for innovative vector control technologies currently being developed. Releasing sterile or lethal gene-carrying male mosquitoes and novel biopesticides may have advantages that are not matched by traditional vector measures in the current context. Here, we review the effects of COVID-19 pandemic on current vector control measures from 2020 to 2021 and discuss the future direction of vector control, taking into account probable evolving conditions of the COVID-19 pandemic.
Keywords: COVID-19; mosquito biological control; mosquito novel control; mosquito-borne diseases; vector control.
Copyright © 2023 Lu, Sui, Lobo, Fouque, Gao, Lu, Lv, Deng and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- World Health Organization . World malaria report 2022. Geneva: World Health Organization. (2022). Available at: https://www.who.int/multi-media/details/introducing-the-world-malaria-re.... (Accessed January 21, 2022).
-
- World Health Organization . Dengue and severe dengue. Geneva: World Health Organization (2022). Available at: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue. (Accessed January 10, 2022).
-
- Chanda-Kapata P, Ntoumi F, Kapata N, Lungu P, Mucheleng'anga LA, Chakaya J, et al. . Tuberculosis, HIV/AIDS and malaria health services in sub-Saharan Africa–a situation analysis of the disruptions and impact of the COVID-19 pandemic. Int J Inf Secur. (2022) 124:S41–6. doi: 10.1016/j.ijid.2022.03.033 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
